. Author manuscript; available in PMC: 2017 Apr 1.

Published in final edited form as: Psychoneuroendocrinology. 2016 Jan 12;66:195–204. doi: 10.1016/j.psyneuen.2016.01.008

Table 2.

Correlation matrix (Pearson’s r) among BMI, BDI scores, and cortisol-mediated monocytic TNF production with and without GR and MR blockers.

			BMI	BDI-C	BDI-S	BDI-T	Δ %mono TNF (CoMIR)
			BMI	BDI-C	BDI-S	BDI-T	Cort only	Mifepris.	Spirono.
BDI-C		r	.020
BDI-C		p	.910

BDI-S		r	.427^*	.559^**
BDI-S		p	.010	.000

BDI-T		r	.308	.860^**	.848^**
BDI-T		p	.072	.000	.000

Δ %mono TNF (CoMIR)	Cort only	r	−.396^*	−.163	−.461^**	−.414^*
	Cort only	p	.018	.348	.005	.013

	Mifepris.	r	−.241	.452^*	.178	.376^#	.417^#
	Mifepris.	p	.280	.035	.429	.084	.053

	Spirono.	r	−.298	.145	.128	.136	−.301	.256
	Spirono.	p	.178	.520	.571	.547	.173	.263

	Combo	r	−.587^**	.331	−.432^#	−.142	.604^**	.771^**	.358
	Combo	p	.007	.154	.057	.550	.005	.000	.121

Correlation is significant at the 0.05 level (2-tailed).

^**

Correlation is significant at the 0.01 level (2-tailed).

Correlation is at the 0.10 level (2-tailed).

Body mass index (BMI); Beck Depression Inventory (BDI: C, cognitive/affective; S, somatic; T, total scores). CoMIR, cortisol-mediated inflammation regulation; Cort only, 1μM cortisol with no blockers; Mifepris, cortisol with mifepristone; Spirono, cortisol with spironolactone; Combo, both antagonists; %mono TNF, % TNF-expressing monocytes.